NCT02902770View on ClinicalTrials.gov

Intravenous Lidocaine and Ketorolac for Pain Management

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

October 4, 2018

Study Completion Date

September 10, 2019

Conditions
Pain
Interventions
DRUG

Lidocaine

1.5 mg/kg IV lidocaine drip (given over 10 minutes)

DRUG

Ketorolac Tromethamine

IV ketorolac 30mg push

DRUG

Normal Saline Drip

Normal Saline Drip Placebo given over 10 minutes

DRUG

Normal Saline Push

Normal Saline Push Placebo

All Listed Sponsors
lead

Antonios Likourezos

OTHER

NCT02902770 - Intravenous Lidocaine and Ketorolac for Pain Management | Biotech Hunter | Biotech Hunter